No phaseRecruiting
Intensive Cancer Screening After Cryptogenic Stroke (INCOGNITO)
Intensive Cancer Screening After Cryptogenic Stroke (INCOGNITO) Pilot Randomized Trial
- Sponsor
- Ottawa Hospital Research Institute (Academic or other)
- Enrolment
- 45 planned
- Conditions
- Occult Cancer
- Interventions
- FDG PET/CT; Usual Care
- Ages
- adults, older adults
- Registry
- NCT05733416
Full record on ClinicalTrials.gov
From the registry
The INCOGNITO Pilot Trial is a single centre pilot prospective randomized open-label blinded endpoint (PROBE) trial to assess the feasibility of a full-scale randomized trial to determine whether an occult cancer screening strategy of FDG PET/CT (F-fluorodeoxyglucose positron emission/computed tomography) in addition to usual care increases the number of occult cancers diagnosed after screening compared to usual care cancer screening alone in patients with cryptogenic stroke.
Primary outcomes
- Participant Recruitment
History
Primary completion expected
Last registry update
Started
Registered